Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

406
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
406

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibroblasts: a diverse population of cells balancing homeostasis, wound healing, regeneration, inflammation, fibrosis, and cancer across organs.

JCI insight·2026
Same author

MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer.

Molecular cancer research : MCR·2026
Same author

Brain metastasis from KRAS wild-type pancreatic cancer and organoid correlates: a case report.

Journal of gastrointestinal oncology·2026
Same author

Implantable Microdevices for In Vivo Assessment of Chemotherapy Response in Patient Derived Organoid Orthotopic Pancreatic Cancer Models.

Annals of surgery·2026
Same author

Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer.

Cancer research·2026
Same author

AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic ductal adenocarcinoma spheroids and organoids.

Frontiers in pharmacology·2026

Related Experiment Video

Updated: May 14, 2025

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

23.9K

The hunt for common tumor antigens.

David A Tuveson1

  • 1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.

Science (New York, N.Y.)
|May 8, 2025
PubMed
Summary

Pancreatic cancer cells produce unique, shared peptides that represent promising targets for new cancer therapies. These findings offer a novel approach to pancreatic cancer treatment development.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Pancreatic cancer is a devastating disease with limited effective treatments.
  • Identifying shared molecular targets across patients is crucial for developing broadly applicable therapies.

Purpose of the Study:

  • To investigate the presence and nature of cryptic peptides expressed by pancreatic cancer cells.
  • To evaluate the potential of these shared peptides as therapeutic targets for pancreatic cancer.

Main Methods:

  • Proteomic analysis of pancreatic cancer cell lines and patient tumors.
  • Bioinformatic identification of conserved peptide sequences.
  • In silico analysis of peptide immunogenicity and targetability.

Main Results:

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

6.9K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

9.5K

Related Experiment Videos

Last Updated: May 14, 2025

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

23.9K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

6.9K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

9.5K
  • Discovery of a repertoire of cryptic peptides uniquely expressed by pancreatic cancer cells.
  • Demonstration that these peptides are shared across a significant proportion of pancreatic cancer patients.
  • Identification of specific peptides with high potential for immune-mediated targeting.

Conclusions:

  • Shared cryptic peptides on pancreatic cancer cells represent a novel class of biomarkers and therapeutic targets.
  • Targeting these peptides could lead to the development of effective immunotherapies for pancreatic cancer.
  • Further research is warranted to validate these findings and develop peptide-based therapeutic strategies.